chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Weight bearing difficulty
Clinical narrative: swelling left elbow and knee; pain on the entire left half of body especially her hip, elbow and knee; Fever; Headache; Dizziness; Rapid Heart rate; A spontaneous report was received from a consumer  concerning  herself, a female patient who experienced Dizziness/Dizziness, Rapid heart rate/Tachycardia, Fever/Pyrexia, Headache/Headache, Pain on the entire left half of her body especially her hip, elbow and knee/Arthralgia,  Swelling left elbow and knee/ Joint swelling.   The patient's medical history was not provided.  Products known to have been used by the patient, within two weeks prior to the event, was not provided by the reporter.   On 29-JAN-2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 012M20A) intramuscularly at an unspecified site  for prophylaxis of COVID-19 infection.    After few hours the vaccination on 29-JAN-2021, she had dizziness with rapid heart rate, fever, headache and on 31-JAN-2021 she had  pain on the entire left half of her body especially her hip, elbow and knee with swelling left elbow and knee. Laboratory information at the time of events was not provided. She reported that she was in lot of pain when she called.  Treatment information included Tylenol and Ibuprofen, but the events didn't respond to the medicines.    Action taken with mRNA-1273 in response to the events were unknown.  The events, dizziness with rapid heart rate, fever, headache and pain on the entire left half of her body especially her hip, elbow and knee with swelling left elbow and knee were considered  as unknown.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: My arm was sore (inj site); This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (My arm was sore (inj site)) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE PAIN (My arm was sore (inj site)). At the time of the report, VACCINATION SITE PAIN (My arm was sore (inj site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not reported.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose abnormal, Blood glucose decreased
Clinical narrative: Lower blood sugars; blood sugars stayed below 200 for two weeks; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (Lower blood sugars) and BLOOD GLUCOSE ABNORMAL (blood sugars stayed below 200 for two weeks) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 01IJ20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included Blood sugar increased (From 200 to 500.). Concomitant products included METFORMIN, ERTUGLIFLOZIN PIDOLATE (STEGLATRO), INSULIN GLARGINE, LIXISENATIDE (SOLIQUA), INSULIN GLARGINE (LANTUS), FENOFIBRATE, LISINOPRIL and ATORVASTATIN for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jan-2021, the patient experienced BLOOD GLUCOSE ABNORMAL (blood sugars stayed below 200 for two weeks). On 03-Feb-2021, the patient experienced BLOOD GLUCOSE DECREASED (Lower blood sugars). On 20-Jan-2021, BLOOD GLUCOSE ABNORMAL (blood sugars stayed below 200 for two weeks) had resolved. At the time of the report, BLOOD GLUCOSE DECREASED (Lower blood sugars) outcome was unknown.            Treatment medication was not reported.   This case was linked to MOD-2021-163282, MOD-2021-163282 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction
Clinical narrative: I would like to reports some symptoms I had; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (I would like to reports some symptoms I had) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (I would like to reports some symptoms I had). At the time of the report, ADVERSE DRUG REACTION (I would like to reports some symptoms I had) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Headache; Joint pain in thumbs; Body ache; Nausea; Fatigue; Tenderness; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness), VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache), ARTHRALGIA (Joint pain in thumbs) and MYALGIA (Body ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced TENDERNESS (Tenderness) and VACCINATION SITE PAIN (Sore arm). On 09-Jan-2021, the patient experienced HEADACHE (Headache), ARTHRALGIA (Joint pain in thumbs), MYALGIA (Body ache), NAUSEA (Nausea) and FATIGUE (Fatigue). At the time of the report, TENDERNESS (Tenderness), VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache), ARTHRALGIA (Joint pain in thumbs), MYALGIA (Body ache), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication history was unknown Treatment information was unknown . Consumer wants to know is the efficacy the same whether you get it the 21-42 days? Was the first dose the same as the second dose? If she gets the vaccine after the 42 days does she have to start all over again?
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness, Vaccination site pain
Clinical narrative: Headache; Joint pain in thumbs; Body ache; Nausea; Fatigue; Tenderness; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness), VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache), ARTHRALGIA (Joint pain in thumbs) and MYALGIA (Body ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced TENDERNESS (Tenderness) and VACCINATION SITE PAIN (Sore arm). On 09-Jan-2021, the patient experienced HEADACHE (Headache), ARTHRALGIA (Joint pain in thumbs), MYALGIA (Body ache), NAUSEA (Nausea) and FATIGUE (Fatigue). At the time of the report, TENDERNESS (Tenderness), VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache), ARTHRALGIA (Joint pain in thumbs), MYALGIA (Body ache), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication history was unknown Treatment information was unknown . Consumer wants to know is the efficacy the same whether you get it the 21-42 days? Was the first dose the same as the second dose? If she gets the vaccine after the 42 days does she have to start all over again?
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema, Vaccination site reaction, Vaccination site swelling
Clinical narrative: had a little bit of reaction at the injection site; has grown a great deal; real itchy; got swelling; redness about a foot long; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (had a little bit of reaction at the injection site), PRURITUS (has grown a great deal) and VACCINATION SITE ERYTHEMA (redness about a foot long) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (had a little bit of reaction at the injection site), PRURITUS (has grown a great deal) and VACCINATION SITE ERYTHEMA (redness about a foot long). At the time of the report, VACCINATION SITE REACTION (had a little bit of reaction at the injection site), PRURITUS (has grown a great deal) and VACCINATION SITE ERYTHEMA (redness about a foot long) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Stool analysis
Clinical narrative: Severe headache; Diarrhea started and it still has not gone away; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe headache) and DIARRHOEA (Diarrhea started and it still has not gone away) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) and TRAZODONE for an unknown indication.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced DIARRHOEA (Diarrhea started and it still has not gone away). On 19-Jan-2021, the patient experienced HEADACHE (Severe headache). At the time of the report, HEADACHE (Severe headache) and DIARRHOEA (Diarrhea started and it still has not gone away) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Stool analysis: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Tylenol 1000mg (four times a day), Imodium   This case was linked to MOD-2021-016483.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Illness, Myalgia, Pyrexia
Clinical narrative: feeling a little bit sick; experiencing chills; fever comes and goes; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (feeling a little bit sick), CHILLS (experiencing chills), PYREXIA (fever comes and goes) and MYALGIA (muscle pain) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M2UA) for COVID-19 vaccination.     The patient's past medical history included Back injury (Patient received a shot of Toradol and 600 mg of Ibuprofen for the pain.) since 01-Feb-2021. Previously administered products included for Pain: Ibuprofen  (600mg ) on 11-Feb-2021; for Back injury: Toradol on 11-Feb-2021. Past adverse reactions to the above products included Back injury with Toradol; and Pain with Ibuprofen .    On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced ILLNESS (feeling a little bit sick), CHILLS (experiencing chills), PYREXIA (fever comes and goes) and MYALGIA (muscle pain). At the time of the report, ILLNESS (feeling a little bit sick), CHILLS (experiencing chills), PYREXIA (fever comes and goes) and MYALGIA (muscle pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. Patient mentioned he had twisted his back on 01-FEB-2021 so he received a shot of Toradol and 600 mg of Ibuprofen for the pain.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore at the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore at the injection site.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore at the injection site.). At the time of the report, VACCINATION SITE PAIN (Sore at the injection site.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain
Clinical narrative: extreme exhaustion/Really really tired; sore arm; This spontaneous case was reported by an other and describes the occurrence of FATIGUE (extreme exhaustion/Really really tired) and INJECTION SITE PAIN (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced INJECTION SITE PAIN (sore arm). On 02-Feb-2021, the patient experienced FATIGUE (extreme exhaustion/Really really tired). At the time of the report, FATIGUE (extreme exhaustion/Really really tired) and INJECTION SITE PAIN (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Rash
Clinical narrative: Itching skin; Red rash on hand,Red rash on wrist; Fever 101.4 on Saturday, Fever 102 on Sunday, Fever of 100 on Monday; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (Itching skin), RASH (Red rash on hand,Red rash on wrist) and PYREXIA (Fever 101.4 on Saturday, Fever 102 on Sunday, Fever of 100 on Monday) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M020A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction (no medical history provided). Concomitant products included ADALIMUMAB for Psoriasis, DULOXETINE HYDROCHLORIDE (CYMBALTA), GLIMEPIRIDE (AMARYL), FOLIC ACID, CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID), LEVOTHYROXINE, DULOXETINE, CITALOPRAM, POTASSIUM CHLORIDE, GLIMEPIRIDE, METFORMIN, METOPROLOL and CLONIDINE.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PYREXIA (Fever 101.4 on Saturday, Fever 102 on Sunday, Fever of 100 on Monday). On 02-Feb-2021, the patient experienced PRURITUS (Itching skin) and RASH (Red rash on hand,Red rash on wrist). At the time of the report, PRURITUS (Itching skin) and RASH (Red rash on hand,Red rash on wrist) outcome was unknown and PYREXIA (Fever 101.4 on Saturday, Fever 102 on Sunday, Fever of 100 on Monday) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: left arm got sore; she got tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (left arm got sore) and FATIGUE (she got tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PAIN (left arm got sore) and FATIGUE (she got tired). At the time of the report, VACCINATION SITE PAIN (left arm got sore) and FATIGUE (she got tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment Ibuprofen
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Chills, Dizziness, Dry mouth
Clinical narrative: Heartbeat started beating fast; Feeling weird; Pressure on the right side of her head; Blood pressure went up to 157; Headache on the right side of her head; Dizzy; Chills; Nauseous; Dry mouth; Left ear was hurting; Felt a lot of pressure; Felt groggy; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), EAR PAIN (Left ear was hurting), EAR DISCOMFORT (Felt a lot of pressure), SOMNOLENCE (Felt groggy) and HEART RATE INCREASED (Heartbeat started beating fast) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No recorded medical history).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced DRY MOUTH (Dry mouth), EAR PAIN (Left ear was hurting), EAR DISCOMFORT (Felt a lot of pressure), SOMNOLENCE (Felt groggy), DIZZINESS (Dizzy), CHILLS (Chills) and NAUSEA (Nauseous). On 06-Jan-2021, the patient experienced HEART RATE INCREASED (Heartbeat started beating fast), FEELING ABNORMAL (Feeling weird), HEAD DISCOMFORT (Pressure on the right side of her head), BLOOD PRESSURE INCREASED (Blood pressure went up to 157) and HEADACHE (Headache on the right side of her head). On 06-Jan-2021, HEART RATE INCREASED (Heartbeat started beating fast) and BLOOD PRESSURE INCREASED (Blood pressure went up to 157) had resolved. At the time of the report, DRY MOUTH (Dry mouth), EAR PAIN (Left ear was hurting), EAR DISCOMFORT (Felt a lot of pressure), SOMNOLENCE (Felt groggy), FEELING ABNORMAL (Feeling weird), DIZZINESS (Dizzy), CHILLS (Chills) and NAUSEA (Nauseous) outcome was unknown and HEAD DISCOMFORT (Pressure on the right side of her head) and HEADACHE (Headache on the right side of her head) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, Blood pressure measurement: 157 (Inconclusive) Blood pressure was 157. On 06-Jan-2021, Heart rate: 92-97 (Inconclusive) HEART BEAT WAS BETWEEN 92-97.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       TNo concomitant medications were provided. reatment ADVIL
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Ear pain, Feeling abnormal, Head discomfort, Headache
Clinical narrative: Heartbeat started beating fast; Feeling weird; Pressure on the right side of her head; Blood pressure went up to 157; Headache on the right side of her head; Dizzy; Chills; Nauseous; Dry mouth; Left ear was hurting; Felt a lot of pressure; Felt groggy; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), EAR PAIN (Left ear was hurting), EAR DISCOMFORT (Felt a lot of pressure), SOMNOLENCE (Felt groggy) and HEART RATE INCREASED (Heartbeat started beating fast) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No recorded medical history).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced DRY MOUTH (Dry mouth), EAR PAIN (Left ear was hurting), EAR DISCOMFORT (Felt a lot of pressure), SOMNOLENCE (Felt groggy), DIZZINESS (Dizzy), CHILLS (Chills) and NAUSEA (Nauseous). On 06-Jan-2021, the patient experienced HEART RATE INCREASED (Heartbeat started beating fast), FEELING ABNORMAL (Feeling weird), HEAD DISCOMFORT (Pressure on the right side of her head), BLOOD PRESSURE INCREASED (Blood pressure went up to 157) and HEADACHE (Headache on the right side of her head). On 06-Jan-2021, HEART RATE INCREASED (Heartbeat started beating fast) and BLOOD PRESSURE INCREASED (Blood pressure went up to 157) had resolved. At the time of the report, DRY MOUTH (Dry mouth), EAR PAIN (Left ear was hurting), EAR DISCOMFORT (Felt a lot of pressure), SOMNOLENCE (Felt groggy), FEELING ABNORMAL (Feeling weird), DIZZINESS (Dizzy), CHILLS (Chills) and NAUSEA (Nauseous) outcome was unknown and HEAD DISCOMFORT (Pressure on the right side of her head) and HEADACHE (Headache on the right side of her head) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, Blood pressure measurement: 157 (Inconclusive) Blood pressure was 157. On 06-Jan-2021, Heart rate: 92-97 (Inconclusive) HEART BEAT WAS BETWEEN 92-97.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       TNo concomitant medications were provided. reatment ADVIL
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Nausea, Somnolence
Clinical narrative: Heartbeat started beating fast; Feeling weird; Pressure on the right side of her head; Blood pressure went up to 157; Headache on the right side of her head; Dizzy; Chills; Nauseous; Dry mouth; Left ear was hurting; Felt a lot of pressure; Felt groggy; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), EAR PAIN (Left ear was hurting), EAR DISCOMFORT (Felt a lot of pressure), SOMNOLENCE (Felt groggy) and HEART RATE INCREASED (Heartbeat started beating fast) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No recorded medical history).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced DRY MOUTH (Dry mouth), EAR PAIN (Left ear was hurting), EAR DISCOMFORT (Felt a lot of pressure), SOMNOLENCE (Felt groggy), DIZZINESS (Dizzy), CHILLS (Chills) and NAUSEA (Nauseous). On 06-Jan-2021, the patient experienced HEART RATE INCREASED (Heartbeat started beating fast), FEELING ABNORMAL (Feeling weird), HEAD DISCOMFORT (Pressure on the right side of her head), BLOOD PRESSURE INCREASED (Blood pressure went up to 157) and HEADACHE (Headache on the right side of her head). On 06-Jan-2021, HEART RATE INCREASED (Heartbeat started beating fast) and BLOOD PRESSURE INCREASED (Blood pressure went up to 157) had resolved. At the time of the report, DRY MOUTH (Dry mouth), EAR PAIN (Left ear was hurting), EAR DISCOMFORT (Felt a lot of pressure), SOMNOLENCE (Felt groggy), FEELING ABNORMAL (Feeling weird), DIZZINESS (Dizzy), CHILLS (Chills) and NAUSEA (Nauseous) outcome was unknown and HEAD DISCOMFORT (Pressure on the right side of her head) and HEADACHE (Headache on the right side of her head) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, Blood pressure measurement: 157 (Inconclusive) Blood pressure was 157. On 06-Jan-2021, Heart rate: 92-97 (Inconclusive) HEART BEAT WAS BETWEEN 92-97.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       TNo concomitant medications were provided. reatment ADVIL
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Genital rash, Peripheral swelling
Clinical narrative: swelling of both hands; redness of both hands; itchy rash on testacles; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (swelling of both hands), ERYTHEMA (redness of both hands) and GENITAL RASH (itchy rash on testacles) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PERIPHERAL SWELLING (swelling of both hands), ERYTHEMA (redness of both hands) and GENITAL RASH (itchy rash on testacles). At the time of the report, PERIPHERAL SWELLING (swelling of both hands), ERYTHEMA (redness of both hands) and GENITAL RASH (itchy rash on testacles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Pyrexia
Clinical narrative: fever of 101.8; chills; joint aches; headache; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (fever of 101.8), CHILLS (chills), ARTHRALGIA (joint aches) and HEADACHE (headache) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for an unknown indication.     The patient's past medical history included No adverse event (No medical history reported).   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PYREXIA (fever of 101.8), CHILLS (chills), ARTHRALGIA (joint aches) and HEADACHE (headache). At the time of the report, PYREXIA (fever of 101.8), CHILLS (chills), ARTHRALGIA (joint aches) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Pyrexia
Clinical narrative: felt itching, redness and had a fever; felt itching, redness and had a fever; felt itching, redness and had a fever; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (felt itching, redness and had a fever), ERYTHEMA (felt itching, redness and had a fever) and PYREXIA (felt itching, redness and had a fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced PRURITUS (felt itching, redness and had a fever), ERYTHEMA (felt itching, redness and had a fever) and PYREXIA (felt itching, redness and had a fever). On 07-Jan-2021, PRURITUS (felt itching, redness and had a fever) and PYREXIA (felt itching, redness and had a fever) had resolved. On 10-Jan-2021, ERYTHEMA (felt itching, redness and had a fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore arm; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of MYALGIA (sore arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided) since an unknown date. Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for Cold sores.    On 20-Jan-2021 at 1:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced MYALGIA (sore arm). At the time of the report, MYALGIA (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain in extremity, Pyrexia, Vaccination site swelling
Clinical narrative: Arm pain; Fatigue; Swelling - Near Injection Site; Chills; Fever - Temperature of 99.0F; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Arm pain), FATIGUE (Fatigue), VACCINATION SITE SWELLING (Swelling - Near Injection Site), CHILLS (Chills) and PYREXIA (Fever - Temperature of 99.0F) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), FATIGUE (Fatigue), VACCINATION SITE SWELLING (Swelling - Near Injection Site), CHILLS (Chills) and PYREXIA (Fever - Temperature of 99.0F). At the time of the report, PAIN IN EXTREMITY (Arm pain), FATIGUE (Fatigue), VACCINATION SITE SWELLING (Swelling - Near Injection Site), CHILLS (Chills) and PYREXIA (Fever - Temperature of 99.0F) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided treatment medication include Aleve" - Self medicating to try to alleviate symptoms, "Tylenol" - Self medicating to try to alleviate the symptoms.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Arm is really sore; Pretty significant pain in the arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is really sore) and VACCINATION SITE PAIN (Pretty significant pain in the arm of the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concomitant products included METOPROLOL, PANTOPRAZOLE, CICLOSPORIN (RESTASIS), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and ESCITALOPRAM for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm is really sore) and VACCINATION SITE PAIN (Pretty significant pain in the arm of the injection). At the time of the report, PAIN IN EXTREMITY (Arm is really sore) and VACCINATION SITE PAIN (Pretty significant pain in the arm of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site discomfort, Injection site erythema, Pruritus, Tenderness
Clinical narrative: itching; tenderness to touch; redness at the site of the injection; discomfort at the injection site; A spontaneous report was received from a Healthcare Professional concerning a 66 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events, redness at the site of the injection, discomfort at the injection site, itching, tenderness to touch.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 9 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot batch: 016M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 10 Feb 2021, the patient experienced the events, redness at the site of the injection. discomfort at the injection site. On 15 Feb 2021, the patient experienced the events, itching. tenderness to touch.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events, redness at the site of the injection, discomfort at the injection site, itching, tenderness to touch was not reported.   In Feb 2021 the outcome of events, discomfort at the injection site was resolved.  The outcome of events include, redness at the site of the injection, itching, tenderness to touch was not reported.; Reporter's Comments: Based on the information provide which includes a strong temporal association, a causal association between the reported events and the administration of the mRNA-1273 cannot be excluded. The reported events are consistent with the known safety profile of the mRNA-1273 vaccine .
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: Chills; fatigue; fever over 99.6°C this morning; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (fatigue) and PYREXIA (fever over 99.6°C this morning) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced CHILLS (Chills), FATIGUE (fatigue) and PYREXIA (fever over 99.6°C this morning). At the time of the report, CHILLS (Chills), FATIGUE (fatigue) and PYREXIA (fever over 99.6°C this morning) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Rash
Clinical narrative: Rash all over the body; Was really sick; A spontaneous report was received from a Consumer concerning a 72 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events, rash all over the body, was really sick.  The patient's medical history was not reported. No relevant concomitant medications were reported.  It was reported that the Patient had a cellulitis and she had been on antibiotics for 6 weeks.   On 8 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot batch: 027L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event, Rash all over the body. Rash started on the arm and everything.  On 11 Feb 2021, the patient experienced the event, was really sick and she went to the ER.  Treatment details included Benadryl.  Action taken with mRNA-1273 in response to the events, rash all over the body, was really sick was not reported.   On an unknown date the outcome of events include, rash all over the body and was really sick was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Myalgia
Clinical narrative: Pain at injection site; Headache; Vomiting; Chills; Dizziness; Nausea; Tiredness; Body ache; Fever; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site), HEADACHE (Headache), VOMITING (Vomiting), CHILLS (Chills) and DIZZINESS (Dizziness) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and C25J2CA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site), HEADACHE (Headache), VOMITING (Vomiting), CHILLS (Chills), DIZZINESS (Dizziness), NAUSEA (Nausea), FATIGUE (Tiredness), MYALGIA (Body ache) and PYREXIA (Fever). At the time of the report, VACCINATION SITE PAIN (Pain at injection site), HEADACHE (Headache), VOMITING (Vomiting), CHILLS (Chills), DIZZINESS (Dizziness), NAUSEA (Nausea), FATIGUE (Tiredness), MYALGIA (Body ache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. Treatment included Tylenol and Nyquil
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination site pain, Vomiting
Clinical narrative: Pain at injection site; Headache; Vomiting; Chills; Dizziness; Nausea; Tiredness; Body ache; Fever; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site), HEADACHE (Headache), VOMITING (Vomiting), CHILLS (Chills) and DIZZINESS (Dizziness) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and C25J2CA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site), HEADACHE (Headache), VOMITING (Vomiting), CHILLS (Chills), DIZZINESS (Dizziness), NAUSEA (Nausea), FATIGUE (Tiredness), MYALGIA (Body ache) and PYREXIA (Fever). At the time of the report, VACCINATION SITE PAIN (Pain at injection site), HEADACHE (Headache), VOMITING (Vomiting), CHILLS (Chills), DIZZINESS (Dizziness), NAUSEA (Nausea), FATIGUE (Tiredness), MYALGIA (Body ache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. Treatment included Tylenol and Nyquil
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Herpes zoster, Nausea, Vaccination site erythema
Clinical narrative: nausea; joint pain; fatigue; shingles; redness and swelling at the site of the injection; redness and swelling at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness and swelling at the site of the injection), VACCINATION SITE SWELLING (redness and swelling at the site of the injection), NAUSEA (nausea), ARTHRALGIA (joint pain) and FATIGUE (fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no reported medical history).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness and swelling at the site of the injection) and VACCINATION SITE SWELLING (redness and swelling at the site of the injection). On 22-Jan-2021, the patient experienced HERPES ZOSTER (shingles). On an unknown date, the patient experienced NAUSEA (nausea), ARTHRALGIA (joint pain) and FATIGUE (fatigue). At the time of the report, VACCINATION SITE ERYTHEMA (redness and swelling at the site of the injection), VACCINATION SITE SWELLING (redness and swelling at the site of the injection), NAUSEA (nausea), ARTHRALGIA (joint pain), FATIGUE (fatigue) and HERPES ZOSTER (shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported. Treatment included Topical steroid cream
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: nausea; joint pain; fatigue; shingles; redness and swelling at the site of the injection; redness and swelling at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness and swelling at the site of the injection), VACCINATION SITE SWELLING (redness and swelling at the site of the injection), NAUSEA (nausea), ARTHRALGIA (joint pain) and FATIGUE (fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no reported medical history).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness and swelling at the site of the injection) and VACCINATION SITE SWELLING (redness and swelling at the site of the injection). On 22-Jan-2021, the patient experienced HERPES ZOSTER (shingles). On an unknown date, the patient experienced NAUSEA (nausea), ARTHRALGIA (joint pain) and FATIGUE (fatigue). At the time of the report, VACCINATION SITE ERYTHEMA (redness and swelling at the site of the injection), VACCINATION SITE SWELLING (redness and swelling at the site of the injection), NAUSEA (nausea), ARTHRALGIA (joint pain), FATIGUE (fatigue) and HERPES ZOSTER (shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported. Treatment included Topical steroid cream
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Injection site pain
Clinical narrative: Dizziness; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Injection site pain) and DIZZINESS (Dizziness) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced INJECTION SITE PAIN (Injection site pain). On an unknown date, the patient experienced DIZZINESS (Dizziness). At the time of the report, INJECTION SITE PAIN (Injection site pain) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Nausea
Clinical narrative: experiencing chills; achy joints; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (experiencing chills), ARTHRALGIA (achy joints), NAUSEA (nausea) and FATIGUE (fatigue) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included no adverse event.    On 25-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced CHILLS (experiencing chills), ARTHRALGIA (achy joints), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, CHILLS (experiencing chills), ARTHRALGIA (achy joints), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain
Clinical narrative: Chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PAIN (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced CHILLS (Chills) and PAIN (body aches). At the time of the report, CHILLS (Chills) and PAIN (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.